The State of Texas has sued pharmaceutical firm Eli Lilly & Firm Inc., alleging the corporate engaged in improper practices to affect medical suppliers to prescribe its most commercially profitable medication, together with the GLP-1 drugs Mounjaro and Zepbound, that are indicated for weight reduction and diabetes administration.
Trending
- West Midlands delegation begins Birmingham 2027 promotion
- A rare Jurassic-era fossil has been discovered in India; know all about it | Pets-animals News
- Google Launches Image-to-Video Tool for Product Promotions
- ITS ATLANTA VIDEO: ADEC announces new TDC3X Multiradar detector
- ‘Being a fitness freak, it came to me as big news’: Actor Celina Jaitly swears by this ‘medically-backed’ way to take care of her ‘second heart’ | Fitness News
- Instagram Launches Video Education Series for Edits App
- ITSWC 2025: Thursday sessions guide
- ‘Why do doctors prescribe Metformin for pre-diabetes if it is also used later for diabetes?’ | Health News
Thursday, August 28
Texas Sues Eli Lilly: ‘Big Pharma Compromised Medical Decision-Making’
